Patton Fund Management, Inc. Gilead Sciences, Inc. Transaction History

Patton Fund Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $150,627 - $216,248	2,417 New	2,417 $207,000
Q3 2020 Oct 20, 2020	SELL	$62.1 - $78.08 $940,628 - $1.18 Million	-15,147 Closed	0 $0
Q2 2020 Jul 08, 2020	SELL	$72.34 - $84.0 $233,947 - $271,656	-3,234 Reduced 17.59%	15,147 $1.17 Million
Q1 2020 Apr 15, 2020	BUY	$62.63 - $80.22 $1.15 Million - $1.47 Million	18,381 New	18,381 $1.37 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Patton Fund Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Patton Fund Management, Inc. with notifications on news.